Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Xencor Inc (NASDAQ:XNCR)

21.55
Delayed Data
As of 12:42pm ET
 -0.12 / -0.55%
Today’s Change
9.89
Today|||52-Week Range
29.38
-18.12%
Year-to-Date
No recent news for Xencor Inc.

Today’s Trading

Previous close21.67
Today’s open21.72
Day’s range21.09 - 21.77
Volume91,295
Average volume (3 months)298,242
Market cap$990.8M
Dividend yield--
Data as of 12:42pm ET, 01/24/2017

Growth & Valuation

Earnings growth (last year)+13.46%
Earnings growth (this year)+211.11%
Earnings growth (next 5 years)--
Revenue growth (last year)+191.62%
P/E ratio21.8
Price/Sales20.55
Price/Book5.41

Competitors

 Today’s
change
Today’s
% change
LOXOLoxo Oncology Inc-1.33-3.47%
DERMDermira Inc-0.19-0.67%
EGRXEagle Pharmaceutical...-0.69-1.04%
ACORAcorda Therapeutics ...0.000.00%
Data as of 12:57pm ET, 01/24/2017

Financials

Next reporting dateMarch 22, 2017
EPS forecast (this quarter)-$0.31
Annual revenue (last year)$27.8M
Annual profit (last year)-$17.6M
Net profit margin-63.37%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Bassil I. Dahiyat
Vice President-Finance &
Investor Relations
John J. Kuch
Corporate headquarters
Monrovia, California

Forecasts


Search for Jobs